HeXun Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	205.84	257.67	119.74	85.03
Short-Term Investments	72	72	72	-
Cash & Short-Term Investments	277.84	329.67	191.74	85.03
Cash Growth	-5.03%	71.93%	125.51%	-
Receivables	95.68	22.28	4.98	-
Inventory	9.71	4.6	-	-
Prepaid Expenses	7.92	6.85	9.44	8.37
Other Current Assets	0.34	0.27	5.08	0.01
Total Current Assets	391.5	363.67	211.24	93.4
Property, Plant & Equipment	132.01	113.93	94.27	102.83
Other Intangible Assets	30.44	34.26	41.23	1.75
Other Long-Term Assets	59.02	59.57	57.41	96.64
Total Assets	612.97	571.43	404.15	294.62
Accounts Payable	6.28	2.02	3.23	2.81
Accrued Expenses	6.83	15.92	3.21	1.42
Current Portion of Long-Term Debt	-	2.55	2.35	0.59
Current Portion of Leases	2.95	2.84	2.13	2.07
Current Unearned Revenue	1.39	1.73	3.6	-
Other Current Liabilities	13.41	5.11	5.51	0.93
Total Current Liabilities	30.85	30.17	20.03	7.83
Long-Term Debt	-	34.9	37.26	39.41
Long-Term Leases	30.81	32.32	29.9	32.03
Long-Term Unearned Revenue	-	-	1.5	-
Other Long-Term Liabilities	0.6	0.6	0.6	0.6
Total Liabilities	62.35	98.07	89.28	79.87
Common Stock	460	460	410	360
Additional Paid-In Capital	130.3	130.3	55.3	-
Retained Earnings	-39.68	-116.95	-150.44	-145.25
Shareholders' Equity	550.63	473.36	314.87	214.75
Total Liabilities & Equity	612.97	571.43	404.15	294.62
Total Debt	33.76	72.61	71.64	74.1
Net Cash (Debt)	244.08	257.06	120.11	10.93
Net Cash Growth	12.17%	114.03%	999.17%	-
Net Cash Per Share	5.30	5.67	3.20	0.36
Filing Date Shares Outstanding	46	46	46	30.51
Total Common Shares Outstanding	46	46	41	30.51
Working Capital	360.65	333.5	191.22	85.58
Book Value Per Share	11.97	10.29	7.68	7.04
Tangible Book Value	520.18	439.09	273.64	213.01
Tangible Book Value Per Share	11.31	9.55	6.67	6.98
Machinery	107.65	82.49	63.57	63.23
Leasehold Improvements	28.08	28	21.69	20.92

Source: S&P Capital IQ. Standard template. Financial Sources.